Cover Image
市場調查報告書

Laboratorios Del Dr. Esteve S.A.的產品平台分析

Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 259345
出版日期 內容資訊 英文 39 Pages
訂單完成後即時交付
價格
Back to Top
Laboratorios Del Dr. Esteve S.A.的產品平台分析 Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 39 Pages
簡介

本報告提供Laboratorios Del Dr. Esteve S.A.上的治療藥開發平台現狀及各開發階段比較分析,提供藥物標的,作用機制,給藥途徑,各類型分子的治療藥評估,以及最新的企業新聞和發表,後期階段及中止計劃的相關資訊等。

Laboratorios Del Dr. Esteve S.A.的基本資料

Laboratorios Del Dr. Esteve S.A.概要

  • 主要資訊
  • 企業資料

Laboratorios Del Dr. Esteve S.A.:R&D概要

  • 主要的治療範圍

Laboratorios Del Dr. Esteve S.A.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Laboratorios Del Dr. Esteve S.A.:開發中產品概況

  • 位於臨床實驗階段的開發中產品
    • 位於第二階段的產品/聯合治療模式
    • 位於第一階段的產品/聯合治療模式
  • 位於初期階段的開發中產品
    • 位於前臨床階段的產品/聯合治療模式

Laboratorios Del Dr. Esteve S.A.:藥物簡介

  • E-52862
  • HIV用疫苗

Laboratorios Del Dr. Esteve S.A.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各類型分子
  • 各作用機制

Laboratorios Del Dr. Esteve S.A.:最近的開發平台趨勢

Laboratorios Del Dr. Esteve S.A.:暫停中的計劃

Laboratorios Del Dr. Esteve S.A.:企業發表

Laboratorios Del Dr. Esteve S.A.:總公司和子公司的所在地

Laboratorios Del Dr. Esteve S.A.:主要製造設備

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07029CDB

Summary

Global Markets Direct's, 'Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015', provides an overview of the Laboratorios Del Dr. Esteve S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Del Dr. Esteve S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laboratorios Del Dr. Esteve S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laboratorios Del Dr. Esteve S.A.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laboratorios Del Dr. Esteve S.A.'s pipeline products

Reasons to buy

  • Evaluate Laboratorios Del Dr. Esteve S.A.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laboratorios Del Dr. Esteve S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laboratorios Del Dr. Esteve S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laboratorios Del Dr. Esteve S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Del Dr. Esteve S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laboratorios Del Dr. Esteve S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laboratorios Del Dr. Esteve S.A. Snapshot
    • Laboratorios Del Dr. Esteve S.A. Overview
    • Key Information
    • Key Facts
  • Laboratorios Del Dr. Esteve S.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Products Glance
    • Laboratorios Del Dr. Esteve S.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Laboratorios Del Dr. Esteve S.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Laboratorios Del Dr. Esteve S.A. - Drug Profiles
    • (celecoxib + tramadol hydrochloride)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • E-52862
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lucinactant
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gene Therapy for Sanfilippo A Syndrome
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MuMo-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Analysis
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Target
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Route of Administration
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Molecule Type
    • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Mechanism of Action
  • Laboratorios Del Dr. Esteve S.A. - Recent Pipeline Updates
  • Laboratorios Del Dr. Esteve S.A. - Dormant Projects
  • Laboratorios Del Dr. Esteve S.A. - Company Statement
  • Laboratorios Del Dr. Esteve S.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Laboratorios Del Dr. Esteve S.A. - Key Manufacturing Facilities
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laboratorios Del Dr. Esteve S.A., Key Information
  • Laboratorios Del Dr. Esteve S.A., Key Facts
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Indication, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios Del Dr. Esteve S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Combination Treatment Modalities in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Partnered Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Partnered Products/ Combination Treatment Modalities, 2015
  • Laboratorios Del Dr. Esteve S.A. - Phase II, 2015
  • Laboratorios Del Dr. Esteve S.A. - Phase I, 2015
  • Laboratorios Del Dr. Esteve S.A. - Preclinical, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Target, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Route of Administration, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Molecule Type, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Mechanism of Action, 2015
  • Laboratorios Del Dr. Esteve S.A. - Recent Pipeline Updates, 2015
  • Laboratorios Del Dr. Esteve S.A. - Dormant Developmental Projects,2015
  • Laboratorios Del Dr. Esteve S.A., Subsidiaries
  • Laboratorios Del Dr. Esteve S.A., Key Manufacturing Facilities

List of Figures

  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Indication, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Stage of Development, 2015
  • Laboratorios Del Dr. Esteve S.A. - Monotherapy Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Partnered Products in Pipeline, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Target, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Route of Administration, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline by Top 10 Molecule Type, 2015
  • Laboratorios Del Dr. Esteve S.A. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top